Procter & Gamble Health Gestion
Gestion contrôle des critères 2/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Milind Thatte
Directeur général
₹32.2m
Rémunération totale
| Pourcentage du salaire du PDG | 100.0% |
| Durée du mandat du directeur général | 6.6yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | pas de données |
| Durée moyenne du mandat des membres du conseil d'administration | 5.4yrs |
Mises à jour récentes de la gestion
Recent updates
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00
Nov 15
Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)
Nov 05Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)
Jun 08Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹2b |
| Jun 30 2024 | ₹32m | ₹32m | ₹2b |
| Mar 31 2024 | n/a | n/a | ₹2b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | ₹25m | ₹25m | ₹2b |
| Mar 31 2023 | n/a | n/a | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹2b |
| Jun 30 2022 | ₹39m | ₹39m | ₹2b |
| Mar 31 2022 | n/a | n/a | ₹2b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹2b |
| Jun 30 2021 | ₹32m | ₹32m | ₹2b |
| Mar 31 2021 | n/a | n/a | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | ₹17m | ₹26m | ₹2b |
| Mar 31 2020 | n/a | n/a | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹1b |
| Jun 30 2019 | n/a | n/a | ₹1b |
| Mar 31 2019 | n/a | n/a | ₹1b |
| Dec 31 2018 | ₹20m | ₹13m | ₹1b |
Rémunération vs marché: La rémunération totale de Milind ($USD 381.84K ) est dans la moyenne des entreprises de taille similaire sur le marché Indian ($USD 354.64K ).
Rémunération et revenus: La rémunération de Milind a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.
PDG
Milind Thatte (55 yo)
6.6yrs
Titularisation
₹32,234,000
Compensation
Mr. Milind Vasant Thatte, M.Pharm.Sci., M.B.A., has been Managing Director and Executive Director of Procter & Gamble Health Limited (formerly known as Merck Limited) since April 1, 2018. Mr. Thatte had a...
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD & Executive Director | 6.6yrs | ₹32.23m | pas de données | |
| CFO, Finance Head & Executive Director | 1.6yrs | ₹24.94m | pas de données | |
| Non-Executive Independent Chairman of the Board | 40.8yrs | ₹2.33m | 0.036% ₹ 30.8m | |
| Non-Executive Independent Director | 3yrs | ₹2.20m | pas de données | |
| Non-Executive Independent Director | 9.8yrs | ₹2.18m | pas de données | |
| Non-Executive Director | 5.4yrs | pas de données | pas de données | |
| Non-Executive Director | 1.6yrs | pas de données | pas de données |
5.4yrs
Durée moyenne de l'emploi
61.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de PGHL sont considérés comme expérimentés (ancienneté moyenne 5.4 ans).